Our observations that CXCL1 and IL-8 are enhanced by the inclusion of stromal cells in 3D cultures of CRC cells and macrophages indicate that targeting the CXCR1/2 signalling axis may represent a therapeutic target in stromal-dense CRC tumours. Here, CXCL1 is linked to colorectal carcinoma.